Published in Proc Natl Acad Sci U S A on September 14, 1999
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A (2002) 2.60
Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A (2000) 2.49
Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice. Proc Natl Acad Sci U S A (2001) 2.26
Patterning, prestress, and peeling dynamics of myocytes. Biophys J (2004) 1.29
Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects. Expert Rev Mol Med (2009) 1.22
Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin-null mice. J Pathol (2010) 1.20
Gene expression profiling of Duchenne muscular dystrophy skeletal muscle. Neurogenetics (2003) 1.18
Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. Hum Mol Genet (2009) 1.12
SMAD signaling drives heart and muscle dysfunction in a Drosophila model of muscular dystrophy. Hum Mol Genet (2010) 1.10
Mechanisms of muscle weakness in muscular dystrophy. J Gen Physiol (2010) 1.03
Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex. FASEB J (2011) 0.99
Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice. Am J Pathol (2009) 0.92
Secondary coronary artery vasospasm promotes cardiomyopathy progression. Am J Pathol (2004) 0.91
Dystrophin and utrophin expression require sarcospan: loss of α7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice. Hum Mol Genet (2012) 0.90
Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice. Hum Mol Genet (2011) 0.88
Restoration of gamma-sarcoglycan localization and mechanical signal transduction are independent in murine skeletal muscle. J Biol Chem (2010) 0.87
A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome. Skelet Muscle (2013) 0.87
Ex vivo stretch reveals altered mechanical properties of isolated dystrophin-deficient hearts. PLoS One (2012) 0.85
Mutation of delta-sarcoglycan is associated with Ca(2+) -dependent vascular remodeling in the Syrian hamster. Am J Pathol (2007) 0.84
The sarcoglycan-sarcospan complex localization in mouse retina is independent from dystrophins. Neurosci Res (2005) 0.81
Alpha7beta1 integrin does not alleviate disease in a mouse model of limb girdle muscular dystrophy type 2F. Am J Pathol (2007) 0.80
Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping. J Clin Invest (2015) 0.80
The dystrophin-associated glycoprotein complex: what parts can you do without? Proc Natl Acad Sci U S A (2000) 0.80
What do mouse models of muscular dystrophy tell us about the DAPC and its components? Int J Exp Pathol (2014) 0.79
Phenotypic and immunohistochemical characterization of sarcoglycanopathies. Clinics (Sao Paulo) (2011) 0.79
Absence of γ-sarcoglycan alters the response of p70S6 kinase to mechanical perturbation in murine skeletal muscle. Skelet Muscle (2014) 0.79
Gamma-sarcoglycan is required for the response of archvillin to mechanical stimulation in skeletal muscle. Hum Mol Genet (2015) 0.78
The Dystrophin Complex: Structure, Function, and Implications for Therapy. Compr Physiol (2015) 0.77
Collagen VI deficiency reduces muscle pathology, but does not improve muscle function, in the γ-sarcoglycan-null mouse. Hum Mol Genet (2016) 0.75
Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell (1987) 16.01
Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A (1993) 7.18
The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science (1989) 6.80
Membrane organization of the dystrophin-glycoprotein complex. Cell (1991) 6.64
Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature (1986) 6.45
Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature (1992) 6.37
A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol (1993) 5.73
Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol (1988) 4.97
Association of dystrophin and an integral membrane glycoprotein. Nature (1989) 3.80
Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science (1995) 3.66
Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell (1995) 3.53
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol (1997) 3.32
Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature (1991) 3.19
Mechanical function of dystrophin in muscle cells. J Cell Biol (1995) 2.67
Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil (1993) 2.62
Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell (1994) 2.60
Calcium entry through stretch-inactivated ion channels in mdx myotubes. Nature (1990) 2.59
Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science (1990) 2.55
A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature (1987) 2.55
Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet (1995) 2.53
Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem (1990) 2.51
Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol (1998) 2.44
Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet (1996) 2.22
Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet (1995) 2.16
Muscular dystrophies and the dystrophin-glycoprotein complex. Curr Opin Neurol (1997) 2.13
Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol (1998) 1.98
Increased calcium influx in dystrophic muscle. J Cell Biol (1991) 1.94
Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J Neurol Sci (1990) 1.78
A new model for the interaction of dystrophin with F-actin. J Cell Biol (1996) 1.66
Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology (1978) 1.63
Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution. Neuron (1993) 1.60
Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem (1994) 1.56
Role of intracellular calcium in promoting muscle damage: a strategy for controlling the dystrophic condition. Experientia (1978) 1.48
A cluster of basic repeats in the dystrophin rod domain binds F-actin through an electrostatic interaction. J Biol Chem (1998) 1.45
Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain (1979) 1.44
Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul Disord (1997) 1.43
Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy. Hum Mol Genet (1996) 1.39
Serum CK, calcium, magnesium, and oxidative phosphorylation in mdx mouse muscular dystrophy. Muscle Nerve (1988) 1.36
The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol Cell Biochem (1998) 1.35
Heterogeneity of the 59-kDa dystrophin-associated protein revealed by cDNA cloning and expression. J Biol Chem (1994) 1.34
The 87K postsynaptic membrane protein from Torpedo is a protein-tyrosine kinase substrate homologous to dystrophin. Neuron (1993) 1.32
The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Genet (1996) 1.29
Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane. Hum Mol Genet (1996) 1.28
The sarcoglycan complex in limb-girdle muscular dystrophy. Curr Opin Neurol (1998) 1.28
beta-dystrobrevin, a new member of the dystrophin family. Identification, cloning, and protein associations. J Biol Chem (1997) 1.27
Studies of sarcolemmal integrity in myopathic muscle. Neurology (1978) 1.24
Cloning of human basic A1, a distinct 59-kDa dystrophin-associated protein encoded on chromosome 8q23-24. Proc Natl Acad Sci U S A (1994) 1.21
Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene. FEBS Lett (1998) 1.21
Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise. Muscle Nerve (1998) 1.18
beta-dystrobrevin, a member of the dystrophin-related protein family. Proc Natl Acad Sci U S A (1998) 1.17
epsilon-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J Biol Chem (1997) 1.12
Extent of shock-induced membrane leakage in human and mouse myotubes depends on dystrophin. J Cell Sci (1995) 1.11
Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association. J Biol Chem (1997) 1.08
A novel 87,000-Mr protein associated with acetylcholine receptors in Torpedo electric organ and vertebrate skeletal muscle. J Cell Biol (1989) 1.07
The dystrophinopathies: an alternative to the structural hypothesis. Neurobiol Dis (1998) 1.00
Dystrophin-associated protein A0 is a homologue of the Torpedo 87K protein. FEBS Lett (1995) 0.99
Beyond dystrophin: current progress in the muscular dystrophies. Curr Opin Pediatr (1996) 0.96
Ecto-ATPase activity of alpha-sarcoglycan (adhalin). J Biol Chem (1999) 0.89
The membrane hypothesis of Duchenne muscular dystrophy: quest for functional evidence. J Inherit Metab Dis (1992) 0.81
Canine X-linked muscular dystrophy studied with in vivo phosphorus magnetic resonance spectroscopy. Muscle Nerve (1991) 0.77
Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A (1993) 7.18
Myosin VI is an actin-based motor that moves backwards. Nature (1999) 5.69
The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature (1991) 5.40
Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet (2001) 5.18
The kinetic mechanism of myosin V. Proc Natl Acad Sci U S A (1999) 4.56
A 35-A movement of smooth muscle myosin on ADP release. Nature (1995) 4.28
Myosin VI is a processive motor with a large step size. Proc Natl Acad Sci U S A (2001) 3.95
Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci U S A (1998) 3.74
Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science (1995) 3.66
Myosin subfragment-1 is sufficient to move actin filaments in vitro. Nature (1987) 3.44
Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest (1999) 3.06
Kinetic mechanism and regulation of myosin VI. J Biol Chem (2001) 2.93
Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet (1995) 2.53
Production and characterization of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa. Infect Immun (1987) 2.43
A simple analysis of the "phosphocreatine shuttle". Am J Physiol (1984) 2.31
Human cardiac myosin heavy chain genes and their linkage in the genome. Nucleic Acids Res (1987) 2.22
The structure of the rigor complex and its implications for the power stroke. Philos Trans R Soc Lond B Biol Sci (2004) 2.17
Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action. J Clin Invest (1996) 2.09
Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol (1998) 1.98
Myosin motors: missing structures and hidden springs. Curr Opin Struct Biol (2001) 1.98
Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Invest (1998) 1.94
Spare the rod, spoil the regulation: necessity for a myosin rod. Proc Natl Acad Sci U S A (1997) 1.94
Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J Cell Sci (2000) 1.86
Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein. J Cell Biol (2000) 1.82
Who should follow up lung cancer patients after operation? Ann Thorac Surg (2000) 1.79
Myosin light chain phosphorylation affects the structure of rabbit skeletal muscle thick filaments. Biophys J (1996) 1.75
ADP inhibition of myosin V ATPase activity. Biophys J (2000) 1.75
Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest (1995) 1.75
Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol Scand (1999) 1.72
Phosphorylation of myosin in permeabilized mammalian cardiac and skeletal muscle cells. Am J Physiol (1986) 1.66
Myoferlin, a candidate gene and potential modifier of muscular dystrophy. Hum Mol Genet (2000) 1.54
Independent assembly of 1.6 microns long bipolar MHC filaments and I-Z-I bodies. Cell Struct Funct (1997) 1.51
Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett (2000) 1.50
Measurements on permeabilized skeletal muscle fibers during continuous activation. Am J Physiol (1987) 1.49
Extracellular matrix elasticity directs stem cell differentiation. J Musculoskelet Neuronal Interact (2007) 1.47
Quantitative electrophoretic analysis of myosin heavy chains in single muscle fibers. J Appl Physiol (1985) (2001) 1.45
Actin and light chain isoform dependence of myosin V kinetics. Biochemistry (2000) 1.45
In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther (1996) 1.45
Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm. Am J Physiol (1993) 1.43
31P NMR spectroscopy, chemical analysis, and free Mg2+ of rabbit bladder and uterine smooth muscle. J Biol Chem (1986) 1.43
Hormonal modulation of a gene injected into rat heart in vivo. Proc Natl Acad Sci U S A (1991) 1.31
The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Genet (1996) 1.29
Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies. Hum Gene Ther (2001) 1.28
Site-directed mutation of the trigger calcium-binding sites in cardiac troponin C. J Biol Chem (1989) 1.24
Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients. HIV Med (2006) 1.24
Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. N Engl J Med (1988) 1.22
Two conserved lysines at the 50/20-kDa junction of myosin are necessary for triggering actin activation. J Biol Chem (2000) 1.21
Sarcoglycans in muscular dystrophy. Microsc Res Tech (2000) 1.20
Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 achieves global cardiac gene transfer in canines. Mol Ther (2008) 1.18
Kinetic and spectroscopic evidence for three actomyosin:ADP states in smooth muscle. J Biol Chem (2000) 1.18
Velocity of shortening and myosin isozymes in two types of rabbit fast-twitch muscle fibers. Am J Physiol (1986) 1.15
Hemodynamic and electrocardiographic effects of selective coronary angiography in man. N Engl J Med (1966) 1.14
Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). Hum Mol Genet (1996) 1.14
Structural and functional responses of mammalian thick filaments to alterations in myosin regulatory light chains. J Struct Biol (1998) 1.12
Cough due to captopril. West J Med (1987) 1.09
Initiation and maturation of I-Z-I bodies in the growth tips of transfected myotubes. J Cell Sci (1999) 1.08
Visualization of Pseudomonas aeruginosa O antigens by using a protein A-dextran-colloidal gold conjugate with both immunoglobulin G and immunoglobulin M monoclonal antibodies. J Bacteriol (1987) 1.07
Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet (1997) 1.07
Thymosin-beta(4) changes the conformation and dynamics of actin monomers. Biophys J (2000) 1.05
Dysferlin protein analysis in limb-girdle muscular dystrophies. J Mol Neurosci (2001) 1.05
Myosin phosphorylation in permeabilized rabbit psoas fibers. Am J Physiol (1985) 1.05
Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology (1995) 1.04
Muscle cell peeling from micropatterned collagen: direct probing of focal and molecular properties of matrix adhesion. J Cell Sci (1999) 1.04
Medical and physiological considerations in the use of artificial cardiac pacing. I. Am Heart J (1968) 1.02
Changes in interfilament spacing mimic the effects of myosin regulatory light chain phosphorylation in rabbit psoas fibers. J Struct Biol (1998) 1.02
Rescue of skeletal muscles of gamma-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer. Mol Ther (2000) 1.01
Myosin phosphorylation in smooth and skeletal muscles: regulation and function. Prog Clin Biol Res (1990) 1.01
Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21. Am J Hum Genet (1997) 1.01
Noninvasive measurement of gene expression in skeletal muscle. Proc Natl Acad Sci U S A (2000) 1.01
The anti-hypertensive effect of Danshen (Salvia miltiorrhiza) and Gegen (Pueraria lobata) formula in rats and its underlying mechanisms of vasorelaxation. J Ethnopharmacol (2011) 0.99
Overexpression of gamma-sarcoglycan induces severe muscular dystrophy. Implications for the regulation of Sarcoglycan assembly. J Biol Chem (2001) 0.99
Gene therapy using adenovirus vectors. Curr Top Microbiol Immunol (1995) 0.97
Production of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa. Infect Immun (1987) 0.97
Changes in fiber composition of soleus muscle during rat hindlimb suspension. J Appl Physiol (1985) (1988) 0.97
Beyond dystrophin: current progress in the muscular dystrophies. Curr Opin Pediatr (1996) 0.96
IgG antibodies to the histone complex H2A-H2B characterize procainamide-induced lupus. Clin Immunol Immunopathol (1985) 0.96
Efficient transmural cardiac gene transfer by intrapericardial injection in neonatal mice. J Mol Cell Cardiol (1999) 0.96
The ADP release step of the smooth muscle cross-bridge cycle is not directly associated with force generation. Biophys J (1999) 0.95
A case of myiasis in man due to Wohlfahrtia magnifica (Schiner) recorded near Rome. Parassitologia (1999) 0.95
Myosin regulatory light chain phosphorylation and the production of functionally significant changes in myosin head arrangement on striated muscle thick filaments. Biophys J (1995) 0.94
Mutation of the high affinity calcium binding sites in cardiac troponin C. J Biol Chem (1992) 0.94
LacZ gene transfer into tumor cells abrogates tumorigenicity and protects mice against the development of further tumors. Gene Ther (1996) 0.93
Procainamide elicits a selective autoantibody immune response. Clin Exp Immunol (1986) 0.92
Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice. Neuromuscul Disord (2001) 0.91
Recombinant adenovirus-mediated cardiac gene transfer of superoxide dismutase and catalase attenuates postischemic contractile dysfunction. Circulation (1998) 0.91
The light chain-binding domain of the smooth muscle myosin heavy chain is not the only determinant of regulation. J Biol Chem (1998) 0.91
Function of the N-terminal calcium-binding sites in cardiac/slow troponin C assessed in fast skeletal muscle fibers. J Biol Chem (1991) 0.89
Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants. Infection (2010) 0.89
Novel actin crosslinker superfamily member identified by a two step degenerate PCR procedure. FEBS Lett (1995) 0.88
Dispensability of the actin-binding site and spectrin repeats for targeting sarcomeric alpha-actinin into maturing Z bands in vivo: implications for in vitro binding studies. Dev Biol (1998) 0.88